USE OF THE HUMAN CELLULAR LINES OF THE PROSTATE TO TREAT THE PROSTATE CANCER.

摘要

An allogeneic immunotherapeutic agent for the treatment of prostate cancer in a patient, comprising three human prostate cell lines from three different sources, of which one, two or three cell lines derive from normal tissue (s), where Each of said normal tissue (s) comes from a source that is non-cancerous prostate, and where cell lines from three different sources are genetically and immunologically non-coincident with the patient.